Company / Interest Expense
Cocrystal Pharma, Inc. Interest Expense History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$4.0K
FY2021
5-year range
-$5.2M / $58.0K
FY2017-FY2021
Trend
-78.9%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $58,000 to $4,000 over the past 2 years.
Based on SEC 10-K filings.
$4,000 in FY2021.
Improved from $58,000 to $4,000 over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, interest expense decreased 78.9% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $4.0K | -78.9% |
| FY2020 | $19.0K | -67.2% |
| FY2019 | $58.0K | +101.1% |
| FY2012 | -$5.2M | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026